Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1649]
News [6503]
Articles [99]
Editorials [4]
Conferences [186]
elearning [21]
Predicting late distant metastases in ER / HER2- breast cancer patients
Dr Peter Dubsky - Medical University of Vienna, Austria
Predicting late distant metastases in ER / HER2- breast cancer patients ( Dr Peter Dubsky - Medical University of Vienna, Austria )
17 Dec 2012
Investigation of Ki67 biomarker
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Investigation of Ki67 biomarker ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
17 Dec 2012
Effects of obesity in breast cancer patients
Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA
Effects of obesity in breast cancer patients ( Dr Clifford Hudis – Memorial Sloan Kettering Cancer Center, New York, USA )
14 Dec 2012
The AZURE translational study
Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
The AZURE translational study ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
14 Dec 2012
Diagnosis of blood cancer after a breast cancer diagnosis
Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA
Diagnosis of blood cancer after a breast cancer diagnosis ( Prof Antonio Wolff - The Johns Hopkins Hospital, Baltimore, USA )
14 Dec 2012
Neratinib shows beneficial effects in the treatment of HER2 mutated breast...
Prof Ron Bose – Washington University School of Medicine, St. Louis, USA
Neratinib shows beneficial effects in the treatment of HER2 mutated breast cancer ( Prof Ron Bose – Washington University School of Medicine, St. Louis, USA )
12 Dec 2012
Breast cancer genome sequencing identified HER2 mutations as targets for drug...
Prof Ron Bose - Washington University School of Medicine, St Louis, USA
Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment ( Prof Ron Bose - Washington University School of Medicine, St Louis, USA )
12 Dec 2012
Colon cancer microenvironments preventing invasion and metastasis
Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan
Colon cancer microenvironments preventing invasion and metastasis ( Dr Makoto Mark Taketo – Kyoto University Graduate School of Medicine, Japan )
20 Nov 2012
RAB5, master regulator of tumour, mesenchymal invasive programmes
Dr Giorgio Scita – IFOM University of Milan, Italy
RAB5, master regulator of tumour, mesenchymal invasive programmes ( Dr Giorgio Scita – IFOM University of Milan, Italy )
20 Nov 2012
Regulation of self-renewal in cancer stem cells
Prof Pier Giuseppe Pelicci – European Institute of Oncology, Milan, Italy
Regulation of self-renewal in cancer stem cells ( Prof Pier Giuseppe Pelicci – European Institute of Oncology, Milan, Italy )
20 Nov 2012
Interplay between pathologies of ovarian cancer and genomics
Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012
Benefit of exercise to cancer survivors
Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands
Benefit of exercise to cancer survivors ( Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands )
14 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation